INSIGHTS ON DRUG DEVELOPMENT

• Development Of A Non-Standard Protein Therapeutic

  Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

• Viral Gene Therapy: Reducing Costs To Improve Patient Access

  Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

• Nanomedicine Modalities Find Path To Clinic Through Analytics

  Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.

• Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging

  High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.

• Delving Into Gene Expression Data Analysis And Experimental Reproducibility

  3/5/2026

  Scientific reproducibility is essential for credible research. Learn to navigate standardized frameworks, refine normalization techniques, and ensure your data remains transparent and verifiable.

• Aggregate Analysis Of Semaglutide

  12/11/2025

  Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

• Leveraging Softgel To Extend Vinorelbine's Lifecycle, Improve Patient Convenience

  3/20/2026

  Develop innovative oral formulations of traditionally intravenous therapies to enhance patient convenience, ensure consistent systemic exposure, and support long-term brand value and market differentiation.

• Comprehensive Workflow For The Quantification Of Peptides And Proteins

  7/29/2025

  Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.

• Navigating Nitrosamine Impurities In Pharmaceutical Drug Development

  3/3/2026

  Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.